CTNM
Contineum Therapeutics
CTNM
CTNM
62 hedge funds and large institutions have $106M invested in Contineum Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3.86% less ownership
Funds ownership: 82.87% → 79% (-3.9%)
54% less capital invested
Capital invested by funds: $231M → $106M (-$126M)
Holders
62
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$912K | |
| 2 | +$827K | |
| 3 | +$604K | |
| 4 |
Morgan Stanley
New York
|
+$214K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$141K |
Top Sellers
| 1 | -$3.89M | |
| 2 | -$2.93M | |
| 3 | -$1.04M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$639K |
| 5 |
Squarepoint
New York
|
-$602K |